Skip to content

Hemodynamic Assessment During Spinal Anesthesia Using Transthoracic Echocardiography'

Hemodynamic Assessment During Spinal Anesthesia Using Transthoracic Echocardiography'

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02315937
Acronym
SATE
Enrollment
35
Registered
2014-12-12
Start date
2016-09-30
Completion date
2016-12-31
Last updated
2016-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension, Hypovolemia

Brief summary

Rationale: Spinal anesthesia is a safe, frequently used anesthetic technique. The main side effect of spinal anesthesia is hypotension, occuring in up to 85 % of selected cases. This hypotension is often treated with fluid infusion. However, especially in elderly patients, high volume fluid infusion can lead to fluid overload. The effects of spinal anesthesia on preload and fluid responsiveness are not exactly known. Hence, therapy for hypotension after spinal anesthesia might not be adequate. With transthoracic echocardiography, vena cava inferior diameter and collapsibility can be used to monitor fluid responsiveness and guide fluid management. Objective: This study has two main objectives. The first is to explore the effects of spinal anesthesia on hemodynamic parameters of fluid status, especially vena cava inferior diameter and collapsibility. The second goal is to test the interrater variability transthoracic echocardiography exams when performed by (trained) anesthesiologists. Furthermore, the correlation between vena cava inferior collapsibility and the occurence and degree of hypotension (defined as a decrease from baseline of \>20% or a systolic pressure \< 90 mmHg) after spinal anesthesia will be explored.

Interventions

PROCEDUREtransthoracic echocardiography

measurement of inferior vena cava diameter during inspiration and expiration using transthoracic echocardiography

Sponsors

Catharina Ziekenhuis Eindhoven
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult age (\>18 years) * Written informed consent * Minor surgery under the umbilicus, e.g. herniorrhaphy, transurethral resection of bladder or prostate, orthopaedic procedures * ASA class I or II

Exclusion criteria

* No informed consent * ASA class III or higher * Obstetric surgery * Emergency procedures * Pre-existing neurological injury or disease * Contra-indications for spinal anesthesia (e.g. coagulation abnormalities)

Design outcomes

Primary

MeasureTime frameDescription
vena cava inferior collapsibility (in %)1 hourvena cava inferior collapsibility: (Maximum vena cava inferior diameter - Minimum vena cava diameter)/maximum vena cava diameter

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026